Objective: Distal stent graft-induced new entry (SINE) can occur after thoracic endovascular aortic repair (TEVAR) of type B aortic dissection. This study investigated the mechanism of distal SINE and its prevention using a restrictive bare stent (RBS) technique.
Thoracic endovascular aortic repair (TEVAR) for type B aortic dissection (TBAD) was introduced in 1999, and promising short-term to midterm outcomes have been reported during the last decade. 1, 2 However, distal stent graft-induced new entry (SINE), a complication related to the stent graft, is being increasingly reported. Study has revealed that nearly 34.8% of SINEs are located at the distal end of the thoracic stent graft 3 and are associated with a mortality rate of 25%. 4 Management of distal SINE is commonly secondary TEVAR, in which another thoracic stent graft is used to cover the new distal entry. 5 However, coverage of the intercostal arteries at the level of T8-T12 increases the risk of spinal ischemia, paraplegia, and paraparesis. Therefore, the prevention of distal SINE is an important issue. A contributing factor to the occurrence of distal SINE may be mismatch between the comparatively larger size of the thoracic stent graft, which was determined by the proximal landing zone, and the smaller size of the highly tapered true lumen of the dissected descending aorta. To reduce this mismatch, we began to use the restrictive bare stent (RBS) technique in 2014. The key point of this technique is to place a bare stent in the descending aorta at the level of the intended distal end of the endograft, before the introduction and deployment of the thoracic stent graft. The purpose of this study was to report our results using the RBS technique for the prevention of distal SINE in TEVAR for TBAD and to investigate the possible mechanism of distal SINE.
METHODS
Selection of patients. From January 2013 to December 2014, 68 consecutive TBAD patients received endovascular repair at our center. Among them, 23 patients received TEVAR with a single thoracic stent graft (TEVAR group); the rest received TEVAR combined with the RBS technique (TEVAR þ RBS group, n ¼ 45). The definitions of TBAD stage (acute, subacute, and chronic) used in this study were those described in the VIRTUE Registry.
The protocol for this study was approved by the Institutional Review Board. All patients provided written informed consent for all surgical procedures.
RBS surgical technique. Since 2014, the RBS technique was used for TBAD patients with distal oversizing (between the diameter of the thoracic stent graft and the descending aorta true lumen diameter at the level of the intended distal edge of the thoracic stent graft) >20%, as previously described by Feng et al. 8 All procedures were performed under general anesthesia. The size of the thoracic stent graft was selected according to the aorta diameter of the proximal landing zone assessed by preoperative computed tomography angiography (CTA), with 10% to 20% oversizing (the actual size used was adjusted according to the size interval of the specific type of thoracic stent graft). 9 The size of the RBS (sinus-XL Stent; OptiMed, Ettlingen, Germany) was selected according to the true lumen diameter of the descending aorta at the level of the intended distal edge of the thoracic stent graft, with 0% to 20% oversizing, as previously described or determined by the surgeon's evaluation. 7, 8, 10 Vascular access was obtained through a surgically isolated femoral artery, and a proper-sized sheath was inserted using the puncture method. After aortography, the RBS was introduced in a retrograde manner through the femoral arteriotomy along with a preset stiff guidewire and advanced to the intended level of the descending aorta, reserving about 30 to 40 mm for overlap with the thoracic stent graft. After the RBS was deployed and secure, the thoracic stent graft was introduced into the proximal landing zone and deployed to seal the proximal entry tear. The main point of this technique is to restrict the distal edge of the thoracic stent graft by the RBS to reduce its possible excessive distal oversizing. Thus, the RBS has to be deployed before the thoracic stent graft.
Follow-up protocol. All patients received CTA at 7 days after surgery, then at 3, 6, and 12 months and yearly thereafter. Overall aortic size, blood flow, diameter of the two lumens, endoleaks, occurrence of distal SINE, and characteristics of the stent grafts were evaluated.
Data collection and definitions. CTA images before and after the primary TEVAR were collected. The entire thoracic aorta was evaluated at four different levels, as described in the report by Gorlitzer et al 11 and by our determinations (Fig 1) . The diameters of the false and true lumens were measured directly distal to the origin of the left subclavian artery (level A), at the level of the pulmonary artery (level B), at the level of the distal edge of the thoracic stent graft (level C), and at the level of the distal edge of the RBS (level D). Changes in true and false lumen diameters, expressed as a ratio (change ratio) to the preoperative baseline lumen diameter, were evaluated for significance over the follow-up time.
The definition and mathematical calculations used are as follows. 
RESULTS
Characteristics of the patients. The characteristics of patients in both groups are summarized in Table I . The mean age of patients was 54.0 6 13.8 years in the TEVAR group (n ¼ 23) and 51.2 6 9.8 years in the TEVAR þ RBS group (n ¼ 45). The thoracic stent grafts used were Valiant (Medtronic, Santa Rosa, Calif), Zenith TX2 (Cook Medical, Bloomington, Ind), TAG (first generation; W. L. Gore & Associates, Flagstaff, Ariz), Ankura (LifeTech Scientific, Shenzhen, China), and Hercules-T (MicroPort Medical, Shanghai, China). Details of the stent grafts and RBSs are presented in Table II . There was no significant difference in the thoracic stent grafts used in the TEVAR group compared with the TEVAR þ RBS group (Table II; P > .05).
Comparisons between patients with distal SINEs and those without SINEs. There were four distal SINES, and the median time at diagnosis was 8 months. Most of them (3/4 [75.0%]) were asymptomatic and identified on follow-up CTA. Patients with distal SINE onset were all subacute cases. There were no significant differences in diameter of the proximal landing zone, diameter of the distal landing zone, taper ratio, and diameter of the distal edge of the stent graft between the two groups Thirty-day mortality 0 ( Table III) . The proximal oversizing of the distal SINE group and non-SINE group was statistically similar (12.8% 6 3.1% vs 11.5% 6 2.3%; P ¼ .288). However, the distal oversizing of the distal SINE group (69.7% 6 35.5%) was significantly greater than that of the non-SINE group (31.2% 6 24.5%; P ¼ .005). Data of each SINE patient are presented in Table IV . Patient 1 returned to our center 3 months after the primary TEVAR, and an asymptomatic distal SINE at the distal edge of the thoracic stent graft was revealed by follow-up CTA. Secondary TEVAR (Valiant, 28-28-150 mm) was performed, and the patient was free from any complication during the 45 months of follow-up. Patient 4 experienced sudden chest pain 3 months after the primary TEVAR. CTA revealed a distal SINE and a coexisting proximal SINE, but the patient refused further intervention. At 6 months after the primary TEVAR, the proximal and distal new entries were significantly expanded, and secondary TEVAR was performed to treat the proximal and distal SINEs (proximal SINE: TAG, 37-37-200 mm; distal SINE: TAG, 37-37-150 mm þ RBS, sinus-XL, 26-80 mm). After the secondary intervention, the patient was free from any complications during the 39 months of follow-up. The other two patients chose medical observation without secondary intervention, and one of them died of a suspected aortic rupture 12 months after the primary TEVAR. Thus, the mortality due to a distal SINE in this series was 25.0% (1/4).
Comparison of the morphologic data and outcomes between the TEVAR and TEVAR þ RBS groups. Preoperative CTA revealed no significant differences in diameter of the proximal landing zone, proximal oversizing, and diameter of the thoracic stent graft between the TEVAR and TEVAR þ RBS groups (Table II) . However, the distal oversizing in the TEVAR group was significantly greater than in the TEVAR þ RBS group (59.8% 6 24.7% vs 16.7% 6 7.6%, respectively; P < .05).
There were no differences in 30-day mortality and postoperative complications between the two groups (Table I) . During the follow-up period (TEVAR group, 34.6 6 4.8 months [range, 12-47 months]; TEVAR þ RBS group, 30.1 6 5.1 months [range, 16-35 months]), four distal SINEs occurred in the TEVAR group, with none occurring in the TEVAR þ RBS group (17.4% vs 0%; P ¼ .011). In addition, as previously stated, one of the distal SINE patients had a coexisting proximal SINE. There were no significant differences in follow-up mortality, aorta-related mortality, secondary interventions, and aorta-related secondary interventions. The 36-month cumulative freedom from SINE of the two groups represented by Kaplan-Meier curves is shown in Fig 2 . Aortic remodeling. Remodeling of the aorta at four different levels is plotted in Fig 3. In each group, the true lumen was significantly increased at all of the four levels during the follow-up time, whereas the false lumen was significantly reduced only at levels A, B, and C (P < .05). Importantly, the total lumen ratio of level D in the TEVAR group exceeded 1, which meant that the false lumen at this level progressively enlarged during the 24 months after the endovascular repair (P ¼ .893). On the other hand, the total lumen ratio of level D in the TEVAR þ RBS group did not exceed 1, which meant that the false lumen at this level decreased during the followup period (P ¼ .152). A comparison of morphologic data over time between the TEVAR and TEVAR þ RBS group is presented in Table V . As can be noted, implantation of an RBS resulted in expansion of the true lumen at level D 24 months after surgery, but the difference between the two groups was not significant (TEVAR group, 24.4 6 2.5 mm; TEVAR þ RBS group, 25.7 6 3.0 mm; P ¼ .085). However, compared with the TEVAR group, the false lumen at the level of the RBS distal edge was significantly reduced in the TEVAR þ RBS group during the 24 months after surgery (P ¼ .029).
DISCUSSION
Mismatch between proximal and distal oversizing is one of the main reasons of distal SINE occurrence. Excessive oversizing of the distal graft and a highly tapered distal true lumen can result in an increased radial force at the distal edge of the thoracic stent graft. 12 In addition, it has been suggested that "spring back," the tendency of Proximal oversizing: meaning the oversizing ratio at the level of the proximal landing zone, defined as (X Stent À X Pro )/X Pro Â 100%. c Distal oversizing: meaning the oversizing ratio at the presumed distal end of the thoracic stent graft or RBS, defined as follows: TEVAR group: (X Stent À X Dis )/X Dis Â 100%; RBS group: (X RBS À X Dis )/X Dis Â 100%. Expansion mismatch ratio of the true lumen at the level of the distal edge of the thoracic stent graft: meaning the expansion mismatch of the true lumen between the distal edge of the stent graft and the nonstented segment 2 cm away from the stent edge, defined as (X true /X true 0 ) Â 100%. Proximal oversizing: meaning the oversizing ratio at the level of the proximal landing zone, defined as (X Stent À X Pro )/X Pro Â 100%. c Distal oversizing: meaning the oversizing ratio at the presumed distal end of the thoracic stent graft or RBS, defined as follows: TEVAR group: (X Stent À X Dis )/X Dis Â 100%; RBS group: (X RBS À X Dis )/X Dis Â 100%. d Expansion mismatch ratio of the true lumen at the level of the distal edge of the thoracic stent graft: meaning the expansion mismatch of the true lumen between the distal edge of the stent graft and the nonstented segment 2 cm away from the stent edge, defined as (X true /X true 0 ) Â 100%. a bent, hard tube to return to its original unbent position and size, can also add stress to the dissected descending aorta. 13 It is believed that these factors can induce tears at the distal end of a stent graft over time. The results of our study showed that the proximal oversizing of the TEVAR group was 12.0% 6 2.5%, whereas the distal oversizing was 59.8% 6 24.7%, with high distal SINE rate (17.4%). So, we wished to evaluate whether excessive distal oversizing of the stent graft contributed to the occurrence of distal SINEs. In this study, we compared factors such as TBAD stage, taper ratio, proximal oversizing, distal oversizing, and diameter of the distal edge of the stent graft between patients who did and did not develop a distal SINE (Table III) . It has been reported that some complications, such as retrograde type A dissection, may be associated with the fragile aortic intima in the acute setting, 6, 14 but all the distal SINEs in this study occurred in subacute cases. Thus, onset of distal SINE may not be related to the unstable intima in the acute phase. Moreover, our results revealed that the taper ratio between the distal SINE and nondistal SINE groups was not different (31.5 6 13.1 vs 26.4 6 8.2; P ¼ .249), suggesting that a high taper ratio might not be a risk factor for the development of a distal SINE. However, our results indicated that distal oversizing (69.7% 6 35.5% vs 31.2% 6 24.5%; P ¼ .005) and expansion mismatch ratio (132.2% 6 16.9% vs 106.5% 6 11.6%; P < .05) were significantly different between the distal SINE and nondistal SINE groups, respectively. These results mean that extensive distal oversizing of the thoracic stent graft will cause an excessive mismatch between the true lumen of the distal stent edge and the true lumen of the nonstented segment away from the stent edge. This mismatch ratio might directly contribute to the development of a distal SINE. Several suggestions have been made for the prevention of distal SINE. To decrease the misalignment between the device and the aortic intima, a study suggested that TEVAR performed during the acute phase and using stent grafts longer than 145 mm could decrease the incidence of distal SINE in TBAD patients. 15 However, as the length of the covered stent graft is increased, so will be the risk of spinal ischemia or paraplegia, especially in acute or subacute patients without enough compensatory spinal blood supply. To decrease distal oversizing and expansion mismatch ratio, several tapered stent grafts have been designed, such as the EndoFit stent graft (LeMaitre Vascular, Burlington, Mass). 16 However, only larger size stent grafts are tapered (>36 mm in diameter), and the taper ratio is limited (<6%). Most of them were used for the treatment of aneurysmal pathologic processes but not dissection. [17] [18] [19] [20] In addition, a fixed, molded, tapered stent graft could not fit the varying anatomy of TBAD patients. According to our data, the mean diameter of the true lumen at the nonstented segment beyond the distal edge of the stent graft at 24 months of follow-up was 24.4 6 2.5 mm, which was significantly smaller than the distal diameter of the existing tapered stent graft. Taken together, this information suggests that the use of an RBS to reduce distal oversizing may decrease or prevent the occurrence of a distal SINE.
The indication for the RBS technique was distal oversizing >20%. One study suggested that proper proximal oversizing of a stent graft for a TBAD is 10% to 20%. 21 However, the remarkably compressed distal true lumen would make the distal oversizing much greater than 20%. Thus, we believe that TBAD patients with an estimated distal oversizing >20% might be at high risk of local intimal trauma at the distal edge of the stent graft. Thus, we consider this an indication for RBS implantation.
The size of the RBS was selected on the basis of the long diameter of the true lumen at the intended distal edge of the stent graft, with 0% to 20% oversizing. 8, 10 Although there is no existing guideline for RBS selection, we believe that proper oversizing helps the bare stent to anchor within the distal true lumen without shifting. Typically, 10% oversizing of a stent graft for dissection is recommended, but the descending aorta of a TBAD is always dissected. The effectiveness of the current criterion remains unknown at the level of a dissected descending aorta with a double lumen. According to our data, the distal oversizing of the TEVAR þ RBS group was only 16.7% 6 7.6%, and there were no distal RBSinduced new entries. After 24 months of follow-up, the diameter of the true lumen at level D (distal edge of the RBS) was 25.7 6 3.0 mm, which was consistent with the mean diameter of the RBS (25.9 6 2.6 mm). No shifting, tortuosity, or disjoining of the RBS was observed. Thus, we believe that application of an RBS with oversizing of 10% to 20% may be much more reasonable, but we do not recommend oversizing >20%.
True lumen expansion is the primary goal of endovascular repair of TBAD. Our results revealed that an RBS could maintain expansion of the true lumen at level D at 24 months after surgery (Fig 3; P < .05) . The size of the RBS was determined by the diameter of the distal true lumen, with appropriate oversizing. Therefore, the RBS not only can restrict the distal edge of the thoracic stent graft from excessive distal oversizing but also can contribute to expansion of the distal true lumen and ensure the perfusion of branch vessels, especially in patients with distal malperfusion. Importantly, we found that the false lumen at this level of the TEVAR group progressively enlarged during the 24 months after endovascular repair (P ¼ .893); the false lumen in the TEVAR þ RBS group at this level decreased during the same follow-up period (P ¼ .152; Fig 3) . Although the difference was not statistically significant, we believe this is an important finding suggesting that the false lumen at the level of the distal descending aorta would progressively expand without true lumen stenting, whereas bare-metal stenting at this level can result in reduction of the false lumen. Studies have suggested that the key factors leading to aortic remodeling are true lumen repressurization and false lumen decompression (thrombosis). 22, 23 In our study, the complete thrombosis rates of the false lumen of the stented segment were 69.6% in the TEVAR group and 80.0% in TEVAR þ RBS group (P ¼ .337; Table I ). Therefore, we believe that significant false lumen reduction at level D in the TEVAR þ RBS group may result from true lumen repressurization as a result of the radial force of the RBS and true lumen repatency. Other factors, such as distal entry and pressure from perfusion of the distal false lumen, also influence aortic remodeling, and as such the relation of RBS and aortic remodeling requires further investigation.
The extensive application of bare-metal stents should be based on specific criteria and should be considered with great caution. One study stated that adjunctive bare-metal stenting did not compromise branch vessel perfusion. 24 However, an experimental study reported a pressure gradient drop in the abdominal branch vessels in 25% of cases after bare-metal stenting. 25 When the branch vessels were supplied by the false lumen, a higher rate (54.5%) of pressure gradient drop was noted.
In our series, we extended the RBS only to the level of the distal descending aorta in three patients with distal malperfusion and extremely compressed distal true lumen. During the follow-up period, no spinal ischemia occurred in any of these patients, and no secondary interventions were necessary. This suggests that distal bare-metal stenting could be performed to the level of the distal descending aorta in the case of distal malperfusion syndrome to expand the compressed distal true lumen.
As we have no experience with RBS stenting to the abdominal aorta, its use to the level of the visceral arteries cannot be recommended. Several new distal bare-metal stent systems have been developed, such as the Zenith Dissection Endovascular System (Cook Medical), which is composed of the Zenith TX2 TAA Endovascular Graft with Pro-Form, a proximal stent graft, and the Zenith Dissection Endovascular Stent, a distal bare-metal stent component. 26, 27 However, the bare-metal stent is designed for providing intimal support to the remaining aorta without obstruction of vital distal side branches, not restriction. In our study, the RBS reduced distal oversizing and intimal damage by restricting the distal edge of the stent graft, without obstruction of vital branches.
There are limitations to this study. The study was performed at a single center, it was retrospective and nonrandomized, and a number of different devices were used. Although specific types of stents (three Zenith, one TAG) and stage (subacute) seemed to be related to distal SINE occurrence, the event rate was too small for any conclusions to be drawn. Thus, the conclusions of this study should be interpreted with caution.
CONCLUSIONS
Excessive distal oversizing may be a significant factor in distal SINE development in patients with TBAD treated by TEVAR. Placement of an RBS may significantly reduce distal oversizing, protect the intima at the distal edge of the thoracic stent graft, and lower the incidence of distal SINE with intended distal oversizing >20%. In addition, it may improve remodeling of the dissected aorta at the corresponding level. Our results revealed promising short-term to midterm outcomes, but long-term effectiveness requires further observation. 
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